Skip to content

Form 4 filed by ARCH Venture Fund XIII, L.P.

ARCH Venture Fund XIII, L.P. filed this Form 4 on LYEL (Lyell Immunopharma, Inc.) with 1 transaction row and 2 holding rows, accepted by EDGAR 2026-11-05 22:34:18 UTC.

Accession
0001012975-26-001013
Filed
2026-11-05
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: LYEL · Lyell Immunopharma, Inc. (CIK 1806952)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-11-04P bought+2,321,262$10.773,747,790I See Footnote
Common Stock holding 910,317I See Footnote
Common Stock holding 910,317I See Footnote